Assessment of Conventional and Molecular Methods in the Routine Management of Tuberculosis in a High Tuberculosis Burden Setting
Open Access
- 29 September 2023
- journal article
- research article
- Published by Maad Rayan Publishing Company in Epidemiology and Health System Journal
- Vol. 10 (3) , 118-125
Abstract
Background and aims: India is a high-burden tuberculosis region and a drug-resistance hotspot. Despite numerous reports of pulmonary tuberculosis (PTB) cases, there needs to be more literature available on the importance of diagnostic methods in the case of extrapulmonary tuberculosis (EPTB). A prospective study was carried out from July 2017 to June 2018 to compare the efficacy of conventional and molecular methods in detecting PTB and EPTB cases. Methods: 1000 presumptive PTB and 412 EPTB cases were subjected to staining (Ziehl-Neelson and fluorescent staining), culture, GeneXpert, and line probe assay. Results: The sensitivity, specificity, and strength of association, i.e., kappa (k) value of LED-FM, ZN, and GeneXpert, were calculated using standard formulae using solid culture as the gold standard. The sensitivity of GeneXpert in smear-positive/culture-positive PTB was comparable with the smear-negative/culture-positive PTB cases (95.7% Vs. 87.5%) with an overall sensitivity and specificity of 90.5% and 90.1% in EPTB cases, respectively. However, sensitivity was lower for pleural fluid (75%) and tissues (85.7%). In pulmonary instances, 10% (6.7% RIF + INH resistant and 3.3%INH monoresistant) drug resistance was observed, and no drug resistance was found in extra-pulmonary samples. Conclusion: Among conventional methods, Fluorescent staining is more sensitive than Ziehl-Neelson (ZN) staining, while the sensitivity of GeneXpert varies w.r.t type of sample using culture positivity as the gold standard. The present study suggests the promotion of universal DST for all individuals with TB to control drug-resistant tuberculosis.Keywords
This publication has 21 references indexed in Scilit:
- Rapid Implementation of New TB Diagnostic Tests: Is It Too Soon for a Global Roll-Out of Xpert MTB/RIF?The American Journal of Tropical Medicine and Hygiene, 2012
- Evaluation of the GeneXpert MTB/RIF Assay for Rapid Diagnosis of Tuberculosis and Detection of Rifampin Resistance in Pulmonary and Extrapulmonary SpecimensJournal of Clinical Microbiology, 2011
- Comparison of Two Molecular Methods for Rapid Diagnosis of Extrapulmonary TuberculosisJournal of Clinical Microbiology, 2011
- GeneXpert—A Game-Changer for Tuberculosis Control?PLOS Medicine, 2011
- Comparison of the Xpert MTB/RIF Test with an IS 6110 -TaqMan Real-Time PCR Assay for Direct Detection of Mycobacterium tuberculosis in Respiratory and Nonrespiratory SpecimensJournal of Clinical Microbiology, 2011
- Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation studyThe Lancet, 2011
- Pediatric Tuberculosis: Global Overview and ChallengesClinical Infectious Diseases, 2010
- Rapid Detection of Mycobacterium tuberculosis and Rifampin Resistance by Use of On-Demand, Near-Patient TechnologyJournal of Clinical Microbiology, 2010
- Modeling the emergence of the 'hot zones': tuberculosis and the amplification dynamics of drug resistanceNature Medicine, 2004
- THE STAINING OF ACID-FAST TUBERCLE BACTERIAScience, 1941